Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mangalam OrganicsNSE:MANORG +0.41%79 EBITDA Margin % is 12.44% as of Jun. 2026, which is 2% below its 10-year median of 12.72. GuruFocus rates NSE:MANORG with a GF Score™ of 79/100 and a GF Value™ of ₹560.23 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,581 Chemicals companies, Mangalam Organics ranks better than 61.99% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Mangalam Organics's EBITDA for the
three
months ended in Jun. 2026 was ₹223 Mil. Mangalam Organics's Revenue for the
three
months ended in Jun. 2026 was ₹1,791 Mil. Therefore, Mangalam Organics's EBITDA margin for the quarter that ended in Jun. 2026 was 12.44%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Mangalam Organics EBITDA Margin % Related Terms
Mangalam Organics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Mangalam Organics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MANORG vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Mangalam Organics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mangalam Organics EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Mangalam Organics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Mangalam Organics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mangalam Organics (NSE:MANORG) has a EBITDA Margin % of 12.44% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mangalam Organics and its competitors. This is near median its historical median of 12.72. According to the industry distribution chart, Mangalam Organics ranks #601 out of 1581 companies in the Chemicals industry, placing it in the top 38%.
Is Mangalam Organics' EBITDA Margin % too high?
Mangalam Organics' current EBITDA Margin % of 12.44% is near median its 10-year median of 12.72. The Chemicals industry median EBITDA Margin % is 9.92. Mangalam Organics' value of 12.44% is 25.4% above this industry median. Based on the distribution chart, Mangalam Organics ranks #601 out of 1581 companies in the Chemicals industry, which is above the industry midpoint. Overall, Mangalam Organics has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mangalam Organics' EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Mangalam Organics ranks #601 out of 1581 companies for EBITDA Margin %. This puts Mangalam Organics in the upper half of its industry. The industry median EBITDA Margin % is 9.92. Mangalam Organics' value of 12.44% is 25.4% above this benchmark. While the company's 10-year median is 12.72 vs. the industry median of 9.92, Mangalam Organics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.92, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mangalam Organics's current EBITDA Margin % of 12.44% is 25.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mangalam Organics and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mangalam Organics's current EBITDA Margin % is 12.44%, which is near median its own 10-year median of 12.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mangalam Organics stock overvalued right now?
Based on GuruFocus' analysis, Mangalam Organics (NSE:MANORG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹560.23, compared to a current price of ₹451.90 — trading 19.3% below its estimated fair value. The current EBITDA Margin % is 12.44%, which is near median its 10-year median of 12.72 and 25.4% above the Chemicals industry median of 9.92. Mangalam Organics' overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Mangalam Organics (NSE:MANORG), the current EBITDA Margin % is 12.44% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mangalam Organics (NSE:MANORG) Overvalued in 2026?
Based on GuruFocus' analysis, Mangalam Organics stock appears to be undervalued.
The current stock price of ₹451.90 is trading 19.3% below its estimated GF Value™ of ₹560.23.
GuruFocus considers Mangalam Organics to be Modestly Undervalued.
Key valuation signals for NSE:MANORG:
EBITDA Margin %: 12.44% (near median its 10-year median of 12.72)
GF Value™: ₹560.23 vs. price of ₹451.90 (19.3% below fair value)
Industry Position: 25.4% above the Chemicals median (#601 of 1581)
No single metric tells the full story. See the NSE:MANORG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mangalam Organics Ltd is an India-based company involved in manufacturing chemicals. It is engaged in manufacturing Camphor, Resin, and Sodium Acetate. It has Terpenes and Synthetic Resins as a primary segment, which falls under a single segment of chemicals. Its production unit is located in Kumbhivali, Maharashtra state, India. The terpene products segment, which generates a vast majority of the revenue, includes Camphor technical, Camphene, Isobornyl acetate, Isoborneol, Dipentene, Camphor oil, Pine tar, Pine oil among others. Its resin products include Penta ester gum, Glycerol ester gum, and Gum rosin among others.
79GF Score
Get the complete analysis for NSE:MANORG
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANORG has been successfully added to your 
